GLENMARK PHARMACEUTICALS
Back to Income Statement
|
GLENMARK PHARMACEUTICALS Last 5 Year Earnings Per Share (EPS) History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Adjusted EPS | ₹-53.21 | ₹10.53 | ₹33.37 | ₹34.38 | ₹27.50 |
What is the latest Earnings Per Share (EPS) of GLENMARK PHARMACEUTICALS ?
| Year | Earnings Per Share (EPS) |
|---|---|
| Mar2025 | ₹-53.21 |
| Mar2024 | ₹10.53 |
| Mar2023 | ₹33.37 |
| Mar2022 | ₹34.38 |
| Mar2021 | ₹27.50 |
How is Earnings Per Share (EPS) of GLENMARK PHARMACEUTICALS Trending?
| Years | Earnings Per Share (EPS) | % Change | |
|---|---|---|---|
| Mar2025 | ₹-53.21 | Negative | |
| Mar2024 | ₹10.53 | -68.44 | |
| Mar2023 | ₹33.37 | -2.94 | |
| Mar2022 | ₹34.38 | 25.02 | |
| Mar2021 | ₹27.50 | - | |
Compare Earnings Per Share (EPS) of peers of GLENMARK PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLENMARK PHARMACEUTICALS | ₹55,614.6 Cr | -1% | -3.7% | 32.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹391,488.0 Cr | -2.5% | -7% | -8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹159,415.0 Cr | -2.2% | -7.2% | 1.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹132,906.0 Cr | -4% | 2.8% | 27.1% | Stock Analytics | |
| CIPLA | ₹106,210.0 Cr | -5.5% | -12.4% | -5.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,089.0 Cr | 5.9% | -3.7% | -6.5% | Stock Analytics | |
GLENMARK PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLENMARK PHARMACEUTICALS | -1% |
-3.7% |
32.7% |
| SENSEX | -2.4% |
-4.7% |
6.4% |
You may also like the below Video Courses